Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that creates next-generation biologic medicines for immune-mediated diseases. It was founded in 2022 and is headquartered in San Carlos, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Attovia Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Attovia Therapeutics Inc. market cap is $1.08B.
What is the 52-week high for Attovia Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Attovia Therapeutics Inc. 52 week high is $28.00 as of September 16, 2026.
What is the 52-week low for Attovia Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Attovia Therapeutics Inc. 52 week low is $16.15 as of September 16, 2026.
What is Attovia Therapeutics Inc. stock price today?
Attovia Therapeutics Inc. stock price today is $23.70.
What was Attovia Therapeutics Inc. stock price yesterday?
Attovia Therapeutics Inc. stock price yesterday was $24.52.
What is the Price-to-Book ratio of Attovia Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Attovia Therapeutics Inc. P/B ratio is -7.4381.
What is the 50-day moving average of Attovia Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Attovia Therapeutics Inc. 50-day moving average is $21.41.